RAAA yields 3.55% · PFE yields 6.13%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, RAAA + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of RAAA + PFE for your $10,000?
RAAA uses up to 50% leverage through reverse repurchase agreements to increase exposure to USDdenominated collateralized loan obligations (CLOs). It seeks income and capital preservation by focusing on AAArated CLO tranches, the senior and highestquality part of a CLO structure backed by pools of loans, including leveraged loans. CLOs must be rated AAA or deemed comparable by the adviser. Up to 20% of assets may be allocated to AA or Arated CLOs. A bottomup process evaluates manager skill, deal structure, collateral, cash flow, and trading frequency, emphasizing larger and more liquid transactions. Investments may also include ETFs with similar strategies. Most holdings are floatingrate and sourced from both primary and secondary markets, with allocations adjusted based on market trends. The fund is nondiversified but limits holdings of any single CLO or manager to 20% to help manage risk while pursuing income and credit quality.
Full RAAA Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.